Activity of Twenty-One Antimicrobial Agents Including /-Ofloxacin against Quinolone-Sensitive and -Resistant, and Methicillin-Sensitive and -Resistant Staphylococcus aureus

Authors:
  • ICIsabell Cooper
    Isabell Cooper
  • KWKeith E. Willard
    Keith E. Willard
  • CFClaudine E. Fasching
    Claudine E. Fasching
  • LSLeann M. Sinn
    Leann M. Sinn
  • CSCarol J. Shanholtzer
    Carol J. Shanholtzer
  • DGDale N. Gerding
    Dale N. Gerding

Abstract
There is a need to identify alternative agents to vancomycin for the treatment of infections with methicillin-resistant Staphylococcus aureus (MRSA). One candidate is the l isomer of ofloxacin (DR-3355). We tested 520 frozen MRSA isolates, 248 fresh MRSA isolates, and 375 fresh methicillin-susceptible S. aureus (MSSA) isolates from Minnesota, and 600 clinical isolates of S. aureus (150 MRSA and 450 MSSA) from Illinois. Over 90% of the MRSA strains were resistant to 32 μg/ml of oxacillin. Of the 520 frozen MRSA, 24% were susceptible to ≤ 2 μg/ml ofloxacin, and an additional 74% were susceptible to ofloxacin between 8 and 16 μg/ml. More than 98% of all strains were susceptible to ≤ 16 μg/ml ofloxacin or l-ofloxacin. All the quinolones had a bimodal distribution of in vitro activity, but for only ofloxacin and l-ofloxacin was activity confined to a very narrow range.